RxDoctor Payments Data

Patrick Jones, MD

Orthopaedic Surgery · St Johns, FLNPI 1962718874

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (40.5%), education and food and beverage — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Arthrex at 43.9% of the total. Reporting peaked in 2021 at $33,058 and has fallen 91.3% since, to $2,870 in 2025.

$66,016in general payments, 2019–2025

Across 218 payments — averaging $302.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$29K
  • Smith+Nephew$8K
  • Peerless Surgical Inc.$8K
  • Team 1, LLC$6K
  • Medical Device Business Services, Inc.$5K
  • DJO, LLC$4K
  • plus $7K from 20 others

What the payments were for

  • Grants$26,75041%
  • Travel & lodging$9,03914%
  • Food & beverage$9,93015%
  • Education$20,29731%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,016 in reported general payments places this provider in the 85th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida →

Medicare billing

Part B allowed, 2024
$252,108
Medicare patients
520
Services billed
2,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam479$1,586
Gabapentin17$85
Oxycodone Hcl11$34

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in St Johns

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →